CAS 3817-05-8
:2-(chlorométhyl)quinazolin-4(1H)-one
- 2-(chloromethyl)quinazolin-4(3H)-one
- 4(3H)-quinazolinone, 2-(chloromethyl)-
- 4-Quinazolinol, 2-(Chloromethyl)-
2-(Chloromethyl)-4-hydroxyquinazoline
CAS :Formule :C9H7ClN2ODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :194.61772-(Chloromethyl)quinazolin-4(3H)-one
CAS :2-(Chloromethyl)quinazolin-4(3H)-oneDegré de pureté :97%Masse moléculaire :194.62g/mol2-(Chloromethyl)-4-hydroxyquinazoline
CAS :2-(Chloromethyl)-4-hydroxyquinazolineFormule :C9H7ClN2ODegré de pureté :≥95%Couleur et forme : white crystalline powderMasse moléculaire :194.62g/mol2-(Chloromethyl)quinazolin-4(3H)-one
CAS :Formule :C9H7ClN2ODegré de pureté :95%Couleur et forme :SolidMasse moléculaire :194.622-(Chloromethyl)quinazolin-4(3H)-one
CAS :2-(Chloromethyl)quinazolin-4(3H)-one is a quinazolinone antibacterial agent. It has been shown to have activity against Staphylococcus species, including methicillin-resistant strains. 2-(Chloromethyl)quinazolin-4(3H)-one binds to the bacterial ribosome and inhibits protein synthesis, leading to cell death. The molecule is nucleophilic, which allows it to react with the ribosomal RNA of bacteria. This drug has also been shown to be cytotoxic in vitro and in vivo against human tumor cells. 2-(Chloromethyl)quinazolin-4(3H)-one has been modified by attaching a benzoyl group at the para position on the phenyl ring or by substituting one of its hydrogens with a methyl group at the para position on the phenyl ring. These modifications have resulted in increased anticancer activity for this
Formule :C9H7ClN2ODegré de pureté :Min. 97 Area-%Couleur et forme :PowderMasse moléculaire :194.62 g/mol



